ORS PACA (Southeastern Health Regional Observatory), Faculty of Medicine, Marseille, France.
Centre d'investigation clinique de l'Hôpital Cochin-Pasteur (CIC 1417), Assistance Publique des Hôpitaux de Paris, Paris, France.
Euro Surveill. 2021 Jan;26(3). doi: 10.2807/1560-7917.ES.2021.26.3.2002047.
In October and November 2020, we conducted a survey of 2,678 healthcare workers (HCWs) involved in general population immunisation in France, French-speaking Belgium and Quebec, Canada to assess acceptance of future COVID-19 vaccines (i.e. willingness to receive or recommend these) and its determinants. Of the HCWs, 48.6% (n = 1,302) showed high acceptance, 23.0% (n = 616) moderate acceptance and 28.4% (n = 760) hesitancy/reluctance. Hesitancy was mostly driven by vaccine safety concerns. These must be addressed before/during upcoming vaccination campaigns.
2020 年 10 月至 11 月,我们对参与法国、比利时法语区和加拿大魁北克普通人群免疫接种的 2678 名医护人员(HCWs)进行了一项调查,以评估他们对未来 COVID-19 疫苗的接受程度(即愿意接种或推荐这些疫苗)及其决定因素。在这些医护人员中,48.6%(n=1,302)表示高度接受,23.0%(n=616)表示中等接受,28.4%(n=760)表示犹豫不决/不情愿。犹豫不决主要是由于对疫苗安全性的担忧。在即将到来的疫苗接种活动之前/期间,必须解决这些问题。